ReviewFrontiers in pharmacology2026

Overcoming adaptive resistance in non-small cell lung cancer: integrating targeted therapies, immunotherapy synergy, and nanocarrier delivery.

Luke Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.